Makeda Naomi Jones, MD - Medicare Psychiatry in Christiansted, VI

  1. Home
  2. Psychiatry & Neurology
  3. VI
  4. Christiansted
Makeda Naomi Jones, MD is a medicare enrolled "Psychiatry & Neurology - Child & Adolescent Psychiatry" physician in Christiansted, Virgin Island. She graduated from medical school in 2004 and has 20 years of diverse experience with area of expertise as Psychiatry. Her current practice location is 4007 Estate Diamond Ruby, Christiansted, Virgin Island. You can reach out to her office (for appointments etc.) via phone at (340) 778-6311.

Makeda Naomi Jones is licensed to practice in New York (license number 244126) and she also participates in the medicare program. She may accept medicare assignments (which means she may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance) and her NPI Number is 1952567372.

Contact Information

Makeda Naomi Jones, MD
4007 Estate Diamond Ruby,
Christiansted, VI 00820-4435
(340) 778-6311
Not Available



Physician's Profile

Full NameMakeda Naomi Jones
GenderFemale
SpecialityPsychiatry
Experience20 Years
Location4007 Estate Diamond Ruby, Christiansted, Virgin Island
Accepts Medicare AssignmentsMay be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Makeda Naomi Jones graduated from medical school in 2004
  NPI Data:
  • NPI Number: 1952567372
  • Provider Enumeration Date: 08/05/2008
  • Last Update Date: 11/27/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 3971664442
  • Enrollment ID: I20231129000023

Medical Identifiers

Medical identifiers for Makeda Naomi Jones such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1952567372NPI-NPPES
00R945OtherTXMEDICARE
138708613MedicaidTX

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084F0202XPsychiatry & Neurology - Forensic Psychiatry 244126 (New York)Secondary
2084P0800XPsychiatry & Neurology - Psychiatry 244126 (New York)Secondary
2084P0804XPsychiatry & Neurology - Child & Adolescent Psychiatry 244126 (New York)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Makeda Naomi Jones allows following entities to bill medicare on her behalf.
Entity NameGovernor Juan F Luis Hospital & Medical Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1972503647
PECOS PAC ID: 1153233804
Enrollment ID: O20070515000578

News Archive

New mouse model by FDA's scientists provides platform for improving understanding of Zika virus pathology

A new mouse model developed by scientists at the U.S. Food and Drug Administration may help in exploring the potential activity of Zika virus vaccines and therapeutics.

Cost-effectiveness of potentially life-saving implantable cardioverter defibrillators (ICD) is an important public health issue

The use of implanted defibrillators that keep the heart beating in proper electrical rhythm to prevent cardiac arrest appears to be cost-effective for those patients who receive a significant mortality reduction, according to researchers from Duke Clinical Research Institute (DCRI), Stanford University and the VA Palo Alto Health Care System, Calif. They analyzed eight clinical trials of the devices to arrive at their conclusion.

EMA accepts Otsuka's marketing authorisation application for tolvaptan for treatment of ADPKD

Otsuka Pharmaceutical Co., Ltd. announced today that the European Medicines Agency (EMA) has accepted the submission of a marketing authorisation application (MAA) for the potential approval of tolvaptan for the treatment of autosomal dominant polycystic kidney disease (ADPKD).

FDA approves label change for non-invasive fibroid treatment

InSightec Ltd. has announced that the U.S. Food and Drug Administration (FDA) approved a label change for the company's ExAblate 2000 MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with non-hysteroscopically resectable uterine fibroids.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Makeda Naomi Jones is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Makeda Naomi Jones, MD
1277 E 14th St Apt 601c,
Brooklyn, NY 11230-5286

Ph: (347) 986-9087		Makeda Naomi Jones, MD
4007 Estate Diamond Ruby,
Christiansted, VI 00820-4435

Ph: (340) 778-6311

News Archive

New mouse model by FDA's scientists provides platform for improving understanding of Zika virus pathology

A new mouse model developed by scientists at the U.S. Food and Drug Administration may help in exploring the potential activity of Zika virus vaccines and therapeutics.

Cost-effectiveness of potentially life-saving implantable cardioverter defibrillators (ICD) is an important public health issue

The use of implanted defibrillators that keep the heart beating in proper electrical rhythm to prevent cardiac arrest appears to be cost-effective for those patients who receive a significant mortality reduction, according to researchers from Duke Clinical Research Institute (DCRI), Stanford University and the VA Palo Alto Health Care System, Calif. They analyzed eight clinical trials of the devices to arrive at their conclusion.

EMA accepts Otsuka's marketing authorisation application for tolvaptan for treatment of ADPKD

Otsuka Pharmaceutical Co., Ltd. announced today that the European Medicines Agency (EMA) has accepted the submission of a marketing authorisation application (MAA) for the potential approval of tolvaptan for the treatment of autosomal dominant polycystic kidney disease (ADPKD).

FDA approves label change for non-invasive fibroid treatment

InSightec Ltd. has announced that the U.S. Food and Drug Administration (FDA) approved a label change for the company's ExAblate 2000 MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with non-hysteroscopically resectable uterine fibroids.

Read more News

› Verified 8 days ago


Psychiatry & Neurology Doctors in Christiansted, VI

Dr. Lourdes Neugart, MD
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 4007 Diamond Ruby, Christiansted, VI 00820
Phone: 340-778-6311    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.